View the PDF

Includes: Apalutamide/ADT Displays Long-Term Efficacy in Recurrent Prostate Cancer, Drug combo cuts risk of death in advanced prostate cancer by 40%, 64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC, Future of BPH management lies in precision, personalization, and technology, Targeting enzymes to weaken cancer cells could supercharge prostate cancer treatment, Enzalutamide/Leuprolide Regimen Reduces Risk of Death in Prostate Cancer, PAM50 Biomarker May Predict Apalutamide Efficacy in Prostate Cancer, High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment, PARP1-selective inhibitor/ARPI combination is well tolerated in advanced prostate cancer, Metastasis-Directed Therapy Improves Outcomes in Various Solid Tumors, Bioengineering breathes new life into failed cancer treatment, Dietary pathways in prostate cancer: Insulin and inflammation, Researchers find a new targeted approach to shut down prostate cancer growth, Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy, After cancer: Study explores caring-healing modalities for survivors, and more.